Spero Therapeutics (SPRO) announced that Esther Rajavelu will serve as its president and CEO, effective May 2 and will be nominated for election as a member of the board of directors at Spero’s annual meeting of stockholders. Since January, Rajavelu has been serving as Spero’s interim president and CEO, and has served as CFO, treasurer, and chief business officer since November 2023. She will continue to serve as the company’s CFO and treasurer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRO: